The Patent Finder

Aluminum Compounds for Use in Therapeutics and Vaccines

Valneva SE

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 5 of these applications claim priority to application 13/449,596, filed Apr 18, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 9,884,115Aluminum Compounds for Use in Therapeutics and Vaccines
In force
 · High confidence
Valneva Austria GmbHIn force
High confidence
US 9,895,437Aluminum Compounds for Use in Therapeutics and Vaccines
In force
 · High confidence
Valneva Austria GmbHIn force
High confidence
US 10,668,146Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
In force
 · High confidence
Valneva Austria GmbHIn force
High confidence
US 11,110,170Aluminum Compounds for Use in Therapeutics and Vaccines
In force
 · High confidence
Valneva Austria GmbHIn force
High confidence
US 12,527,863Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
In force
 · High confidence
Valneva Austria GmbHIn force
High confidence
US 9,913,898Aluminum Compounds for Use in Therapeutics and Vaccines
In force
 · High confidence
Valneva Austria GmbHIn force
High confidence
Application 19/411,478Methods for Preparing Aluminum Precipitate Compounds for Use in Therapeutics and Vaccines
Pending
Not granted
Valneva Austria GmbHPendingNot granted
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
6 of these are in force and held by Valneva SE.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited